Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics 2017

Steven Graves's Biography



Steven Graves, Professor, University of New Mexico; President & CEO, BennuBio Inc.

Steven W. Graves received his Ph.D. from The Pennsylvania State University in 1998, joined the National Flow Cytometry Resource at Los Alamos National Laboratory in 1999, became a Technical Staff Member in 2001, and advanced to Team Leader of Optical Spectroscopy and Instrumentation in 2007. He moved to the University of New Mexico in 2008 in the Center for Biomedical Engineering. He is now the Director of the Center for Biomedical Engineering and a Professor of Chemical and Biological Engineering, where his research focuses on the development of biomedical instrumentation, diagnostic assays, and the study of molecular assemblies. Recently, he has applied cellular micromanipulation technologies in combination with inexpensive low-power components to create small low-cost flow cytometry approaches that will be of use both in point of care settings and as in highly parallel flow cytometers. The development of highly parallel flow cytometers led to the development of BennuBio Inc., which is a flow cytometry company dedicated to high throughput cellular analysis and sorting. Another recent interest is the development of molecular assemblies to understand the principles of information transfer in biological systems. He has an h-index of 26, 60 publications, 13 patents, and several awards, including a 2007 R&D100 award for the development of Portable Acoustic Cytometry.

Steven Graves Image

Microfluidic Acoustic Flow Cytometry: A Pathway to Point-of-Care and High-Speed Parallel Cellular Diagnostics

Wednesday, 10 May 2017 at 10:00

Add to Calendar ▼2017-05-10 10:00:002017-05-10 11:00:00Europe/LondonMicrofluidic Acoustic Flow Cytometry: A Pathway to Point-of-Care and High-Speed Parallel Cellular DiagnosticsSELECTBIOenquiries@selectbiosciences.com

I will present our work to develop synergistic technologies that dramatically reduce the cost, size, and operational requirements of an individual flow cytometer, while simultaneously enabling highly parallel flow cytometry analysis of multiple flow streams to dramatically increase analytical throughput.


Add to Calendar ▼2017-05-10 00:00:002017-05-11 00:00:00Europe/LondonPoint-of-Care Diagnostics 2017SELECTBIOenquiries@selectbiosciences.com